EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Adequate vitamin D is associated with favorable disease outcome in children with inflammatory bowel disease receiving anti‐tumor necrosis factor alpha therapy

Adi Anafy iD, Yaara Manor, Maayan Shemer, Reut Doyev, Eytan Damari, Shlomi Cohen, Anat Yerushalmy-Feler

Journal of Pediatric Gastroenterology and Nutrition · 2026

DOI: 10.1002/jpn3.70321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2026. Verfasst von Adi Anafy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Gastroenterology Institute, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Gray Faculty of Medical an…. Hauptthemen laut MEDLINE: Vitamin D, Tumor Necrosis Factor-alpha, Vitamin D Deficiency, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Deficiency of serum 25‐hydroxyvitamin D [25(OH)D] was associated with decreased short‐term response to anti‐tumor necrosis factor‐alpha (TNF‐α) agents in adults with inflammatory bowel disease (IBD). The aim of this study was to evaluate the association between serum 25(OH)D levels and the outcome of children with IBD undergoing anti‐TNF‐α therapy.

Methods

Children with IBD who were treated with anti‐TNF‐α agents and whose 25(OH)D levels had been measured at the initiation of therapy were included. Demographic, clinical, and laboratory data were collected retrospectively between 1/2012 and 1/2022. 25(OH)D levels above 30 ng/mL were considered sufficient.

Results

A total of 150 children with IBD were treated with anti‐TNF‐α agents, and 84 of them (58 Crohn's disease, 26 ulcerative colitis, median [interquartile range] age 15.2 [12.8–16.5] years) met the inclusion criteria. Sixty‐five (77%) patients were 25(OH)D‐deficient. Adequate 25(OH)D levels were associated with clinical response (hazard ratio [HR] = 4, 95% confidence interval [CI] 1.43–11.11, p = 0.008), and clinical remission (HR = 4.62, 95% CI 2.56–8.33, p < 0.001). While anti‐TNF‐α trough levels were comparable between 25(OH) d ‐deficient and non‐deficient children, intensification of anti‐TNF‐α therapy was more prevalent among children with 25(OH)D deficiency (65% vs. 21%, p < 0.001).

Conclusions

Adequate serum 25(OH)D is an independent predictor of a favorable outcome of pediatric IBD under anti‐TNF‐α therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DTumor Necrosis Factor-alphaVitamin D DeficiencyInflammatory Bowel DiseasesColitis, UlcerativeCrohn DiseaseHumansChildMaleFemaleRetrospective StudiesAdolescentTreatment OutcomeInfliximab

Stichwörter der Autor:innen

25(OH)DCrohn's diseaseadalimumabinfliximabulcerative colitis

Substanzen

Vitamin DTumor Necrosis Factor-alpha25-hydroxyvitamin DInfliximab

Autor:innen und Institutionen

  • Pediatric Gastroenterology Institute, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Department of Pediatrics, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Department of Pediatrics, Assuta Ashdod University Medical Center, Ashdod, Israel, and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

ORCID-Profile: Adi Anafy

Förderung

  • None

Zitieren

APA

Anafy, A., Manor, Y., Shemer, M., Doyev, R., Damari, E., Cohen, S., & Yerushalmy-Feler, A. (2026). Adequate vitamin D is associated with favorable disease outcome in children with inflammatory bowel disease receiving anti‐tumor necrosis factor alpha therapy. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70321

Vancouver

Anafy A, Manor Y, Shemer M, Doyev R, Damari E, Cohen S, et al. Adequate vitamin D is associated with favorable disease outcome in children with inflammatory bowel disease receiving anti‐tumor necrosis factor alpha therapy. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70321

BibTeX
@article{Anafy2026,
  author = {Anafy, Adi and Manor, Yaara and Shemer, Maayan and Doyev, Reut and Damari, Eytan and Cohen, Shlomi and Yerushalmy-Feler, Anat},
  title = {Adequate vitamin D is associated with favorable disease outcome in children with inflammatory bowel disease receiving anti‐tumor necrosis factor alpha therapy},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  doi = {10.1002/jpn3.70321}
}
Kostenlos starten →